[1]
|
Notarbartolo, S. and Abrignani, S. (2022) Human T Lymphocytes at Tumor Sites. Seminars in Immunopathology, 44, 883-901. https://doi.org/10.1007/s00281-022-00970-4
|
[2]
|
Shih, H., Sciumè, G., Poholek, A.C., et al. (2014) Transcriptional and Epigenetic Networks of Helper T and Innate Lymphoid Cells. Immunological Reviews, 261, 23-49. https://doi.org/10.1111/imr.12208
|
[3]
|
Wan, Y.Y. and Flavell, R.A. (2009) How Diverse-CD4 Effector T Cells and Their Functions. Journal of Molecular Cell Biology, 1, 20-36. https://doi.org/10.1093/jmcb/mjp001
|
[4]
|
Basu, A., Ramamoorthi, G., Albert, G., et al. (2021) Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy. Frontiers in Immunology, 12, Article 669474. https://doi.org/10.3389/fimmu.2021.669474
|
[5]
|
Poncette, L., Bluhm, J. and Blankenstein, T. (2022) The Role of CD4 T Cells in Rejection of Solid Tumors. Current Opinion in Immunology, 74, 18-24. https://doi.org/10.1016/j.coi.2021.09.005
|
[6]
|
Kim, H.-J. and Cantor, H. (2014) CD4 T-Cell Subsets and Tumor Immunity: The Helpful and the Not-So-Helpful. Cancer Immunology Research, 2, 91-98. https://doi.org/10.1158/2326-6066.CIR-13-0216
|
[7]
|
Xie, Q., Ding, J. and Chen, Y. (2021) Role of CD8 T Lymphocyte Cells: Interplay with Stromal Cells in Tumor Microenvironment. Acta Pharmaceutica Sinica B, 11, 1365-1378. https://doi.org/10.1016/j.apsb.2021.03.027
|
[8]
|
Ohshima, K. and Morii, E. (2021) Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis. Metabolites, 11, Article 28. https://doi.org/10.3390/metabo11010028
|
[9]
|
Noer, J.B., Talman, M.-L.M. and Moreira, J.M.A. (2021) HLA Class II Histocompatibility Antigen γ Chain (CD74) Expression Is Associated with Immune Cell Infiltration and Favorable Outcome in Breast Cancer. Cancers, 13, Article 6179. https://doi.org/10.3390/cancers13246179
|
[10]
|
Koyama, S. and Nishikawa, H. (2021) Mechanisms of Regulatory T Cell Infiltration in Tumors: Implications for Innovative Immune Precision Therapies. Journal for ImmunoTherapy of Cancer, 9, e002591. https://doi.org/10.1136/jitc-2021-002591
|
[11]
|
Hariyanto, A.D., Permata, T.B.M. and Gondhowiardjo, S.A. (2022) Role of CD4 CD25 FOXP3 T Reg Cells on Tumor Immunity. Immunological Medicine, 45, 94-107. https://doi.org/10.1080/25785826.2021.1975228
|
[12]
|
Tay, R.E., Richardson, E.K. and Toh, H.C. (2021) Revisiting the Role of CD4 T Cells in Cancer Immunotherapy—New Insights into Old Paradigms. Cancer Gene Therapy, 28, 5-17. https://doi.org/10.1038/s41417-020-0183-x
|
[13]
|
Busselaar, J., Tian, S., Van Eenennaam, H., et al. (2020) Helpless Priming Sends CD8 T Cells on the Road to Exhaustion. Frontiers in Immunology, 11, Article 592569. https://doi.org/10.3389/fimmu.2020.592569
|
[14]
|
Quezada, S.A., Simpson, T.R., Peggs, K.S., et al. (2010) Tumor-Reactive CD4 T Cells Develop Cytotoxic Activity and Eradicate Large Established Melanoma after Transfer into Lymphopenic Hosts. Journal of Experimental Medicine, 207, 637-650. https://doi.org/10.1084/jem.20091918
|
[15]
|
Xie, Y., Akpinarli, A., Maris, C., et al. (2010) Naive Tumor-Specific CD4 T Cells Differentiated in vivo Eradicate Established Melanoma. Journal of Experimental Medicine, 207, 651-667. https://doi.org/10.1084/jem.20091921
|
[16]
|
Perez-Diez, A., Joncker, N.T., Choi, K., et al. (2007) CD4 Cells Can be More Efficient at Tumor Rejection than CD8 Cells. Blood, 109, 5346-5354. https://doi.org/10.1182/blood-2006-10-051318
|
[17]
|
McCaw, T.R., Li, M., Starenki, D., et al. (2019) The Expression of MHC Class II Molecules on Murine Breast Tumors Delays T-Cell Exhaustion, Expands the T-Cell Repertoire, and Slows Tumor Growth. Cancer Immunology, Immunotherapy, 68, 175-188. https://doi.org/10.1007/s00262-018-2262-5
|
[18]
|
McLane, L.M., Abdel-Hakeem, M.S. and Wherry, E.J. (2019) CD8 T Cell Exhaustion during Chronic Viral Infection and Cancer. Annual Review of Immunology, 37, 457-495. https://doi.org/10.1146/annurev-immunol-041015-055318
|
[19]
|
Oh, D.Y., Kwek, S.S., Raju, S.S., et al. (2020) Intratumoral CD4 T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell, 181, 1612-1625. E13. https://doi.org/10.1016/j.cell.2020.05.017
|
[20]
|
Woroniecka, K.I., Rhodin, K.E., Dechant, C., et al. (2020) 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers. Clinical Cancer Research, 26, 1349-1358. https://doi.org/10.1158/1078-0432.CCR-19-1068
|
[21]
|
Woroniecka, K., Chongsathidkiet, P., Rhodin, K., et al. (2018) T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma. Clinical Cancer Research, 24, 4175-4186. https://doi.org/10.1158/1078-0432.CCR-17-1846
|
[22]
|
Alspach, E., Lussier, D.M., Miceli, A.P., et al. (2019) MHC-II Neoantigens Shape Tumour Immunity and Response to Immunotherapy. Nature, 574, 696-701. https://doi.org/10.1038/s41586-019-1671-8
|
[23]
|
Ahrends, T., Spanjaard, A., Pilzecker, B., et al. (2017) CD4 T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness. Immunity, 47, 848-861. https://doi.org/10.1016/j.immuni.2017.10.009
|
[24]
|
Wu, T., Zhang, X., Liu, X., et al. (2023) Single-Cell Sequencing Reveals the Immune Microenvironment Landscape Related to Anti-PD-1 Resistance in Metastatic Colorectal Cancer with High Microsatellite Instability. BMC Medicine, 21, Article No. 161. https://doi.org/10.1186/s12916-023-02866-y
|
[25]
|
Damei, I., Trickovic, T., Mami-Chouaib, F., et al. (2023) Tumor-Resident Memory T Cells as a Biomarker of the Response to Cancer Immunotherapy. Frontiers in Immunology, 14, Article 1205984. https://doi.org/10.3389/fimmu.2023.1205984
|
[26]
|
Brummel, K., Eerkens, A.L., De Bruyn, M., et al. (2023) Tumour-Infiltrating Lymphocytes: From Prognosis to Treatment Selection. British Journal of Cancer, 128, 451-458. https://doi.org/10.1038/s41416-022-02119-4
|
[27]
|
Pizzolla, A., Keam, S.P., Vergara, I.A., et al. (2022) Tissue-Resident Memory T Cells from a Metastatic Vaginal Melanoma Patient Are Tumor-Responsive T Cells and Increase after Anti-PD-1 Treatment. Journal for ImmunoTherapy of Cancer, 10, e004574. https://doi.org/10.1136/jitc-2022-004574
|
[28]
|
Corgnac, S., Malenica, I., Mezquita, L., et al. (2020) CD103 CD8 TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17. Cell Reports Medicine, 1, Article 100127. https://doi.org/10.1016/j.xcrm.2020.100127
|
[29]
|
Baba, Y., Nomoto, D., Okadome, K., et al. (2020) Tumor Immune Microenvironment and Immune Checkpoint Inhibitors in Esophageal Squamous Cell Carcinoma. Cancer Science, 111, 3132-3141. https://doi.org/10.1111/cas.14541
|
[30]
|
Lin, R., Zhang, H., Yuan, Y., et al. (2020) Fatty Acid Oxidation Controls CD8 Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma. Cancer Immunology Research, 8, 479-492. https://doi.org/10.1158/2326-6066.CIR-19-0702
|
[31]
|
Lim, C.J., Lee, Y.H., Pan, L., et al. (2019) Multidimensional Analyses Reveal Distinct Immune Microenvironment in Hepatitis B Virus-Related Hepatocellular Carcinoma. Gut, 68, 916-927. https://doi.org/10.1136/gutjnl-2018-316510
|
[32]
|
Laumont, C.M., Wouters, M.C.A., Smazynski, J., et al. (2021) Single-Cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer. Clinical Cancer Research, 27, 4089-4100. https://doi.org/10.1158/1078-0432.CCR-20-4394
|
[33]
|
Martinez-Usatorre, A., Carmona, S.J., Godfroid, C., et al. (2020) Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells. Frontiers in Immunology, 11, Article 340. https://doi.org/10.3389/fimmu.2020.00340
|
[34]
|
Schauder, D.M., Shen, J., Chen, Y., et al. (2021) E2A-Regulated Epigenetic Landscape Promotes Memory CD8 T Cell Differentiation. Proceedings of the National Academy of Sciences, 118, e2013452118. https://doi.org/10.1073/pnas.2013452118
|
[35]
|
Booth, J.S. and Toapanta, F.R. (2021) B and T Cell Immunity in Tissues and Across the Ages. Vaccines, 9, Article 24. https://doi.org/10.3390/vaccines9010024
|
[36]
|
Gauthier, T. and Chen, W. (2022) Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections. Frontiers in Immunology, 13, Article 780839. https://doi.org/10.3389/fimmu.2022.780839
|
[37]
|
Zhao, S., Peralta, R.M., Avina-Ochoa, N., et al. (2021) Metabolic Regulation of T Cells in the Tumor Microenvironment by Nutrient Availability and Diet. Seminars in Immunology, 52, Article 101485. https://doi.org/10.1016/j.smim.2021.101485
|
[38]
|
Nguyen, K.B. and Spranger, S. (2020) Modulation of the Immune Microenvironment by Tumor-Intrinsic Oncogenic Signaling. Journal of Cell Biology, 219, e201908224. https://doi.org/10.1083/jcb.201908224
|
[39]
|
Safarzadeh, E. (2021) STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells from Breast Cancer Patients. Frontiers in Immunology, 11, Article 613215. https://doi.org/10.3389/fimmu.2020.613215
|
[40]
|
Mao, X., Xu, J., Wang, W., et al. (2021) Crosstalk between Cancer-Associated Fibroblasts and Immune Cells in the Tumor Microenvironment: New Findings and Future Perspectives. Molecular Cancer, 20, Article No. 131. https://doi.org/10.1186/s12943-021-01428-1
|
[41]
|
Dzobo, K. (2020) Cancer-Associated Fibroblasts: Origins, Heterogeneity and Functions in Tumor Microenvironment. OMICS, Preprint. https://doi.org/10.20944/preprints202001.0155.v1
|
[42]
|
Ginefra, P., Lorusso, G. and Vannini, N. (2020) Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy. International Journal of Molecular Sciences, 21, Article 4441. https://doi.org/10.3390/ijms21124441
|
[43]
|
Zadka, Ł. Grybowski, D.J. and Dzięgiel, P. (2020) Modeling of the Immune Response in the Pathogenesis of Solid Tumors and Its Prognostic Significance. Cellular Oncology, 43, 539-575. https://doi.org/10.1007/s13402-020-00519-3
|
[44]
|
Abolhassani, H., Wang, Y., Hammarström, L., et al. (2021) Hallmarks of Cancers: Primary Antibody Deficiency versus Other Inborn Errors of Immunity. Frontiers in Immunology, 12, Article 720025. https://doi.org/10.3389/fimmu.2021.720025
|
[45]
|
Zuo, B., Kuai, J., Long, J., Bian, J., Yang, X., Yang, X., Xun, Z., Li, Y., Sun, H., Sang, X. and Zhao, H. (2022) Differentially Expressed Liver Exosome-Related Genes as Candidate Prognostic Biomarkers for Hepatocellular Carcinoma. Annals of Translational Medicine, 10, 817. https://doi.org/10.21037/atm-21-4400
|
[46]
|
Zhou, P., Chen, L., Yan, D., et al. (2020) Early Variations in Lymphocytes and T Lymphocyte Subsets Are Associated with Radiation Pneumonitis in Lung Cancer Patients and Experimental Mice Received Thoracic Irradiation. Cancer Medicine, 9, 3437-3444. https://doi.org/10.1002/cam4.2987 https://pubmed.ncbi.nlm.nih.gov/32207253/
|
[47]
|
Zhang, J.-J., Zhao, R., Xia, F., et al. (2022) Cost-Effectiveness Analysis of rhTPO and rhIL-11 in the Treatment of Chemotherapy-Induced Thrombocytopenia in Hematological Tumors Based on Real-World Data. Annals of Palliative Medicine, 11, 2709-2719. https://doi.org/10.21037/apm-22-880
|
[48]
|
Vahidi, Y., Bagheri, M., Ghaderi, A., et al. (2020) CD8-Positive Memory T Cells in Tumor-Draining Lymph Nodes of Patients with Breast Cancer. BMC Cancer, 20, Article No. 257. https://doi.org/10.1186/s12885-020-6714-x
|
[49]
|
Gentric, G. and Mechta-Grigoriou, F. (2021) Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective. Cancers, 13, Article 399. https://doi.org/10.3390/cancers13030399
|